Xeris Pharmaceuticals Inc (XERS)

$1.71 0.05 (2.84%)

13:13 EDT XERS Stock Quote Delayed 30 Minutes

XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings Mar 6, 2024

XERS stock results show that Xeris Biopharma Holdings met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Why Is Xeris Biopharma (XERS) Stock Up 12% Today?

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Volume:

Previous Close -

Market Cap 113.71M

PE Ratio -1.20

EPS -1.42

Volume (Avg. Vol.) 524,144

Day's Range $1.70 - $1.76

52-Week Range $1.46 - $3.26

Dividend & Yield N/A (N/A)

XERS Stock Predictions, Articles, and Xeris Pharmaceuticals Inc News

From InvestorPlace
From the Web

XERS Stock Pops on Huge FDA News. Here’s What to Know.

By Larry Ramer, InvestorPlace Contributor Dec 31, 2021

The FDA approved Xeris' Recorlev drug for certain adult patients with Cushing's syndrome, sending XERS stock higher.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 24, 2021

Good morning, investor! We're getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 18, 2021

Good morning, trader! We're halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday!

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Jun 3, 2021

So what did the stock market do today? Investors turned to new meme stocks like XERS and watched the OGN stock spinoff launch.

Get Ready for a XERS Stock Squeeze! Why One Analyst Thinks Xeris Could Be the Next AMC

By Brenden Rearick, InvestorPlace Financial News Writer Jun 3, 2021

XERS stock could very well be the next stock to get the short squeeze treatment, even without a r/WallStreetBets co-sign.

Amgen joins Xeris Biopharma for Tepezza version (NASDAQ:AMGN)

From Seeking Alpha Jan 10, 2024

Xeris Biopharma (XERS) stock gains after the company joined Amgen (AMGN) for a subcutaneous version of the thyroid eye disease therapy, Tepezza. Read more here.

Xeris Biopharma sees FY revenue at higher end of guidance (NASDAQ:XERS)

From Seeking Alpha Jan 4, 2024

Xeris Biopharma Holdings expects higher revenue, positive cashflow, and increased cash reserves in Q4.

Xeris Pharmaceuticals reports Q2 revenue (NASDAQ:XERS)

From Seeking Alpha Aug 10, 2023

Xeris Pharmaceuticals press release (XERS): Q2 revenue of $38M (+50.1% Y/Y) misses by $2.93M.

Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.01, revenue of $38.01M beats by $3.17M (NASDAQ:XERS)

From Seeking Alpha Aug 8, 2023

Xeris Pharmaceuticals press release (XERS): Q2 GAAP EPS of -$0.14 misses by $0.01.Revenue of $38.01M (+50.2% Y/Y) beats by $3.17M.“We posted another record quarter of revenue due to...

Xeris Pharmaceuticals GAAP EPS of -$0.12 beats by $0.05, revenue of $33.2M beats by $2.43M (NASDAQ:XERS)

From Seeking Alpha May 9, 2023

Xeris Pharmaceuticals press release (XERS): Q1 GAAP EPS of -$0.12 beats by $0.05.Revenue of $33.2M (+51.5% Y/Y) beats by $2.43M.FY2023 Outlook: Total revenue of $135M-$165M vs

SVB Securities Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS)

From TipRanks Nov 14, 2022

SVB Securities analyst Roanna Ruiz reiterated a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) on November 9 and set a price target of $6.00. Th...

Xeris Pharmaceuticals Inc (XERS)

XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023

Why Is Xeris Biopharma (XERS) Stock Up 12% Today?

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Xeris Pharmaceuticals Inc (XERS)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

XERS Stock Predictions, Articles, and Xeris Pharmaceuticals Inc News

Subscriber Sign in